Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Petsky Prunier was a leading boutique investment bank that specialized in providing merger and acquisition advisory, private placement, and valuation services. The firm focused on the technology, media, marketing, information, and healthcare industries, with a particular emphasis on mid-market transactions. In February 2019, Petsky Prunier was acquired by Canaccord Genuity Group Inc. to significantly expand its presence and sector expertise in the United States. Following the acquisition, the firm's team and operations were integrated into Canaccord Genuity's global capital markets division. During its operation, Petsky Prunier was well-regarded for its deep industry research and high volume of closed transactions in the digital media and healthcare technology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Petsky Prunier.